The prediction of pathogenic mutations of AMBRA1 and their in vitro validation have been carried out in melanoma, the most aggressive and lethal form of skin cancer, in which AMBRA1 not only bears an anti-tumorigenic function [29], but also displays high mutation rate [26]. This evidence concerns the gene AMBRA1 and skin cancer.